[ad_1]
Now even the EMA acknowledges: the data so far show all that the Omicron variant cases are mostly lighter.
This was stated by the head of the task force for the vaccine against Covid-19 in the European Medicines Agency, Marco Cavaleri, although again he was careful and stressed the need to gather more evidence in order to clearly determine whether the severity spectrum of the disease caused by Omicron is different from that of all the variants that have circulated so far.
“Time will tell. At this stage we do not have enough data to show the impact of the Omicron variant on the efficacy of approved vaccines, but we are constantly monitoring and gathering evidence“, He said.
Cavaleri added that companies trading in Covid-19 vaccines are required to submit laboratory test results to determine the level of neutralization for the Omicron variant, noting that the EMA is ready to act quickly if necessary.
So far, the European Medicines Agency has approved four Pfizer / BioNTech anti-covid vaccines, Moderna, Johnson & Johnson and AstraZeneca.
Meanwhile, the EMA gave the green light to the disease medicine produced by the Merck company, which it considers a successful treatment and can be taken at home.
top channel
[ad_2]
Source link
